Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Phys Chem Chem Phys ; 26(24): 17182-17190, 2024 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-38847738

RESUMO

ZnSeTe quantum dots (QDs) attract growing interest owing to their low threats to health and the environment. They are widely applied as emitters in displays and lighting devices. Previous findings have indicated that inorganic halides are excellent candidates for surface ligands on QDs. By incorporating inorganic halides during the synthesis process, the photoluminescence (PL) intensity and quantum yield (QY) of QDs can be significantly enhanced. However, the alteration of surface states in QDs induced by zinc halide modification and the mechanism of formation of trap-state radiative recombination processes have been less discussed. Herein, we proposed a synthesis strategy for ZnSeTe/ZnSe/ZnSeS/ZnS core/shell/shell/shell QDs modified with ZnCl2, and by comparing the morphology and elemental composition of QDs with different amounts of ZnCl2 added, we revealed the regulatory mechanism of nanocrystal growth in the presence of ZnCl2. QDs with modification of ZnCl2 exhibited broad yellow fluorescence, distinct from the intrinsic blue emission. Through spectroscopic and surface ligand analyses, we attributed this yellow emission to the intermediate state energy levels caused by the defects on the surface. Finally, we used the QDs with broad linewidth emission to fabricate a simple white-light-emitting diode (WLED). This work provided new insights into the role of inorganic ligands and the use of a single emitting material in solid-state lighting devices.

2.
J Phys Chem Lett ; 15(7): 1975-1984, 2024 Feb 22.
Artigo em Inglês | MEDLINE | ID: mdl-38346356

RESUMO

Colloidal quantum dots (QDs) consist of an inorganic core and organic surface ligands. Surface ligands play a dominant role in maintaining the colloidal stability of QDs and passivating the surface defects of QDs. However, the original ligands introduced in the synthetic process of QDs cannot meet the requirements for diverse applications; therefore, ligand exchanges with functional ligands are mandatory. Understanding the ligand exchange process requires a comprehensive combination of the concepts and techniques of surface chemistry. In this Perspective, the ligand exchange process is discussed in detail. Specifically, we elaborate on the thermodynamics that can reveal the feasibility and mechanism of ligand exchange. It depicts a critical physical picture of the surface of QDs along with the following ligand exchange.

3.
Small ; 20(30): e2400254, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38402432

RESUMO

Pyroptosis, a new mode of regulatory cell death, holds a promising prospect in tumor therapy. The occurrence of pyroptosis can trigger the release of damage-associated molecular patterns (DAMPs) and activate the antitumor immune response. Moreover, enhancing intracellular reactive oxygen species (ROS) generation can effectively induce pyroptosis. Herein, an integrated nanoplatform (hCZAG) based on zeolitic imidazolate framework-8 (ZIF-8) with Cu2+ and Zn2+ as active nodes and glucose oxidase (GOx) loading is constructed to evoke pyroptosis. GOx can effectively elevate intracellular hydrogen peroxide (H2O2) levels to regulate the unfavorable tumor microenvironment (TME). Cu2+ can be reduced to Cu+ by endogenous overexpressed GSH and both Cu2+ and Cu+ can exert Fenton-like activity to promote ROS generation and amplify oxidative stress. In addition, the accumulation of Cu2+ leads to the aggregation of lipoylated dihydrolipoamide S-acetyltransferase (DLAT), thus resulting in cuproptosis. Notably, the outburst of ROS induced by hCZAG activates Caspase-1 proteins, leads to the cleavage of gasdermin D (GSDMD), and induces pyroptosis. Pyroptosis further elicits an adaptive immune response, leading to immunogenic cell death (ICD). This study provides effective strategies for triggering pyroptosis-mediated immunotherapy and achieving improved therapeutic effects.


Assuntos
Glucose Oxidase , Piroptose , Espécies Reativas de Oxigênio , Microambiente Tumoral , Piroptose/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Microambiente Tumoral/efeitos dos fármacos , Animais , Glucose Oxidase/metabolismo , Glucose Oxidase/química , Humanos , Camundongos , Cobre/química , Peróxido de Hidrogênio/química , Linhagem Celular Tumoral , Estruturas Metalorgânicas/química , Estruturas Metalorgânicas/farmacologia , Nanopartículas/química , Imunidade/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Imidazóis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA